Antiplatelet medications aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Blood Platelets

Diseases23

Trigger Finger Disorder Hemorrhage Thrombosis Coronary Thrombosis Stroke Acute Coronary Syndrome Myocardial Infarction Postoperative Hemorrhage Recurrence Thromboembolism Coronary Artery Disease Cardiovascular Diseases Gastrointestinal Hemorrhage Drug-Related Side Effects and Adverse Reactions Ischemic Attack, Transient Cerebrovascular Disorders Coronary Disease Thrombocytopenia Brain Ischemia Cerebral Hemorrhage Graft Occlusion, Vascular Purpura, Thrombocytopenic Intracranial Hemorrhages

Chemicals and Drugs42

Aspirin Platelet Aggregation Inhibitors Ticlopidine Anticoagulants Anti-Inflammatory Agents, Non-Steroidal Purinergic P2Y Receptor Antagonists Fibrinolytic Agents Thromboxane B2 Receptors, Purinergic P2Y12 Dipyridamole Thienopyridines Warfarin Thiophenes Phenprocoumon Platelet Glycoprotein GPIIb-IIIa Complex Cyclooxygenase Inhibitors Salicylates Prescription Drugs Sulfinpyrazone Thromboxanes Tetrazoles Antihypertensive Agents Tablets, Enteric-Coated Cardiovascular Agents Psychotropic Drugs Adenosine Diphosphate Heparin Thromboxane A2 Nonprescription Drugs Cyclooxygenase 1 Antipsychotic Agents Phosphodiesterase 3 Inhibitors Piperazines Purinergic P2 Receptor Antagonists Immunoglobulin Fab Fragments Proton Pump Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Pharmaceutical Preparations Drug Combinations Sodium Salicylate Antidepressive Agents Prostaglandin-Endoperoxide Synthases

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Arthrodesis Medication Errors Platelet Function Tests Drug Therapy, Combination Treatment Outcome Medication Reconciliation Risk Factors Bleeding Time Prospective Studies Stents Angioplasty, Balloon, Coronary Follow-Up Studies Drug Prescriptions Double-Blind Method Retrospective Studies Self Medication Risk Assessment Drug-Eluting Stents Randomized Controlled Trials as Topic Polypharmacy Platelet Count Drug Therapy Administration, Oral Drug Administration Schedule Cohort Studies Drug Monitoring Perioperative Care Incidence Thrombelastography Logistic Models Clinical Trials as Topic International Normalized Ratio Multivariate Analysis Percutaneous Coronary Intervention Cross-Sectional Studies

Psychiatry and Psychology2

Medication Adherence Patient Compliance

Phenomena and Processes9

Platelet Aggregation Platelet Activation Bleeding Time Time Factors Dose-Response Relationship, Drug Drug Resistance Drug Interactions Platelet Count Platelet Adhesiveness

Information Science3

Incidence Clinical Pharmacy Information Systems Medical Order Entry Systems

Named Groups1

Health Care30

Medication Adherence Medication Errors Treatment Outcome Medication Reconciliation Medication Systems Medication Systems, Hospital Risk Factors Prospective Studies Follow-Up Studies Drug Prescriptions Double-Blind Method Secondary Prevention Retrospective Studies Patient Compliance Risk Assessment Drug Utilization Randomized Controlled Trials as Topic Cohort Studies Physician's Practice Patterns Perioperative Care Incidence Practice Guidelines as Topic Pharmacists Clinical Pharmacy Information Systems Drug Costs Logistic Models Clinical Trials as Topic Medical Order Entry Systems Multivariate Analysis Cross-Sectional Studies

Geographicals1

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Named Groups Health Care Geographicals

Trigger Finger Disorder Aspirin Platelet Aggregation Inhibitors Ticlopidine Arthrodesis Medication Adherence Medication Errors Platelet Aggregation Platelet Function Tests Drug Therapy, Combination Blood Platelets Hemorrhage Thrombosis Anticoagulants Anti-Inflammatory Agents, Non-Steroidal Purinergic P2Y Receptor Antagonists Treatment Outcome Fibrinolytic Agents Medication Reconciliation Medication Systems Platelet Activation Thromboxane B2 Receptors, Purinergic P2Y12 Medication Systems, Hospital Dipyridamole Coronary Thrombosis Thienopyridines Warfarin Risk Factors Bleeding Time Stroke Thiophenes Acute Coronary Syndrome Phenprocoumon Prospective Studies Time Factors Platelet Glycoprotein GPIIb-IIIa Complex Stents Cyclooxygenase Inhibitors Angioplasty, Balloon, Coronary Myocardial Infarction Follow-Up Studies Drug Prescriptions Double-Blind Method Salicylates Secondary Prevention Retrospective Studies Self Medication Dose-Response Relationship, Drug Drug Resistance Patient Compliance Risk Assessment Postoperative Hemorrhage Prescription Drugs Drug Utilization Drug-Eluting Stents Recurrence Randomized Controlled Trials as Topic Drug Interactions Polypharmacy Platelet Count Sulfinpyrazone Drug Therapy Thromboxanes Administration, Oral Thromboembolism United States Tetrazoles Antihypertensive Agents Coronary Artery Disease Tablets, Enteric-Coated Drug Administration Schedule Cardiovascular Agents Psychotropic Drugs Cardiovascular Diseases Adenosine Diphosphate Gastrointestinal Hemorrhage Drug-Related Side Effects and Adverse Reactions Heparin Cohort Studies Thromboxane A2 Nonprescription Drugs Physician's Practice Patterns Ischemic Attack, Transient Cerebrovascular Disorders Cyclooxygenase 1 Antipsychotic Agents Drug Monitoring Coronary Disease Perioperative Care Incidence Practice Guidelines as Topic Phosphodiesterase 3 Inhibitors Piperazines Purinergic P2 Receptor Antagonists Thrombocytopenia Immunoglobulin Fab Fragments Pharmacists Clinical Pharmacy Information Systems Drug Costs

No FAQ available that match "antiplatelet medications aspirin"